Literature DB >> 18952692

Inflammatory bowel disease unclassified and indeterminate colitis: the role of the pathologist.

K Geboes1, P Van Eyken.   

Abstract

Analysis of multiple biopsies allows a correct diagnosis of inflammatory bowel diseases in 66-75% of newly diagnosed patients. Additional endoscopic and clinical data allow a final diagnosis in more than 90%. Errors or lack of diagnosis are more frequent (up to 7%) in patients with severe inflammatory activity. The terminology for cases without a definite diagnosis is unclear. "Unclassified" and "uncertain" colitis have been proposed as well as "indeterminate colitis". The latter term has become widely used but with a variety of definitions. The common feature of all definitions is that the aetiology and type of colitis can not be identified properly. Pathologists stress the need for colectomy specimens for the diagnosis, while paediatricians, surgeons and gastroenterologists stress the fact that the colitis can not be classified irrespective of the diagnostic tools used. A correct diagnosis is however essential for treatment. For the pathologist who has to provide such a diagnosis, it is important to know the normal histology and the features associated with various forms of colitis and clinical conditions. This paper describes an algorithm for a diagnosis of colitis with a focus on indeterminate colitis.

Entities:  

Mesh:

Year:  2008        PMID: 18952692     DOI: 10.1136/jcp.2008.059311

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Italian consensus conference for colonic diverticulosis and diverticular disease.

Authors:  Rosario Cuomo; Giovanni Barbara; Fabio Pace; Vito Annese; Gabrio Bassotti; Gian Andrea Binda; Tino Casetti; Antonio Colecchia; Davide Festi; Roberto Fiocca; Andrea Laghi; Giovanni Maconi; Riccardo Nascimbeni; Carmelo Scarpignato; Vincenzo Villanacci; Bruno Annibale
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

Review 2.  Early-Onset Inflammatory Bowel Disease.

Authors:  Judith R Kelsen; Pierre Russo; Kathleen E Sullivan
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 3.  Clinical Utility of Biomarkers in IBD.

Authors:  Gerhard Rogler; Luc Biedermann
Journal:  Curr Gastroenterol Rep       Date:  2015-07

4.  Endoscopic and histologic findings in pediatric inflammatory bowel disease.

Authors:  Gareth P Jevon; Ravikumara Madhur
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-03

Review 5.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

Review 6.  Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.

Authors:  Amosy Ephreim M'Koma
Journal:  Medicina (Kaunas)       Date:  2022-04-21       Impact factor: 2.948

7.  The role of FAS gene variants in inflammatory bowel disease.

Authors:  Ayhan Demir; Resul Kahraman; Gonca Candan; Arzu Ergen
Journal:  Turk J Gastroenterol       Date:  2020-05       Impact factor: 1.852

8.  Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition.

Authors:  Ellen Li; Christina M Hamm; Ajay S Gulati; R Balfour Sartor; Hongyan Chen; Xiao Wu; Tianyi Zhang; F James Rohlf; Wei Zhu; Chi Gu; Charles E Robertson; Norman R Pace; Edgar C Boedeker; Noam Harpaz; Jeffrey Yuan; George M Weinstock; Erica Sodergren; Daniel N Frank
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

9.  Gene Expression-Genotype Analysis Implicates GSDMA, GSDMB, and LRRC3C as Contributors to Inflammatory Bowel Disease Susceptibility.

Authors:  Jan Söderman; Linda Berglind; Sven Almer
Journal:  Biomed Res Int       Date:  2015-09-21       Impact factor: 3.411

10.  Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.

Authors:  Ellen Li; Yuanhao Zhang; Xinyu Tian; Xuefeng Wang; Grace Gathungu; Ashley Wolber; Shehzad S Shiekh; R Balfour Sartor; Nicholas O Davidson; Matthew A Ciorba; Wei Zhu; Leah M Nelson; Charles E Robertson; Daniel N Frank
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.